First-in-Human Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

First-in-Human Trials in Mexico

First-in-Human Trials in Mexico – Clinical Trials Services

In recent years, Mexico has emerged as a significant player in the global healthcare landscape, making notable strides in medical research and innovation. One area that has gained substantial attention is the conduct of first-in-human trials. These trials mark the crucial first step in testing novel therapies and medical interventions on human subjects.

In this blog, we will explore the growing prominence of first-in-human trials in Mexico, the factors contributing to this trend, the benefits and challenges associated with these trials, and their potential impact on healthcare advancements in the country.

Emerging Importance of First-in-Human Trials in Mexico

Mexico’s increasing significance in first-in-human trials can be attributed to several factors. First and foremost, the country boasts a robust healthcare infrastructure with world-class research institutions and renowned medical professionals.

Furthermore, Mexico’s diverse population provides a valuable resource for conducting trials, as it offers a broad range of genetic and demographic profiles. Additionally, the streamlined regulatory framework implemented by Mexican authorities has encouraged both domestic and international pharmaceutical companies to choose Mexico as a destination for conducting their clinical trials.

Benefits of First-in-Human Trials

First-in-human trials play a pivotal role in advancing medical knowledge and therapeutic options. These trials allow researchers to evaluate the safety, dosage, and potential efficacy of new interventions in humans for the first time.

By including Mexico in the list of countries hosting such trials, it opens up opportunities for patients to access cutting-edge treatments that may not be available elsewhere. Furthermore, the trials can stimulate collaborations between local and international researchers, fostering knowledge exchange and elevating Mexico’s standing in the global research community.

Challenges and Ethical Considerations

While first-in-human trials hold immense promise, they also come with unique challenges and ethical considerations. The safety of participants is of paramount importance, and rigorous protocols must be followed to minimize risks.

Ensuring informed consent and maintaining transparency throughout the trial process is crucial. Additionally, there is a need for adequate monitoring and regulation to safeguard against any potential exploitation. Mexico has made significant strides in addressing these challenges by aligning its regulations with international standards and working closely with ethical review boards to ensure the protection of participants.

First-in-Human Trials in Mexico

First-in-Human Trials in Mexico

First-in-Human Trials in Mexico

Impact on Healthcare Advancements

The increased participation in first-in-human trials positions Mexico as a key player in driving healthcare advancements. By collaborating with pharmaceutical companies and research institutions, Mexico can attract cutting-edge research projects and clinical trials.

This fosters innovation, attracts investment, and stimulates the growth of the local healthcare industry. Moreover, the knowledge gained from these trials can inform healthcare policies, facilitate the development of personalized medicine, and improve treatment outcomes for patients across the country.

Current Initiatives and Success Stories

Mexico has already witnessed several notable first-in-human trials that have showcased its potential as a hub for medical innovation. For instance, there have been trials testing new cancer therapies, innovative medical devices, and groundbreaking gene therapies. These trials have not only provided patients with access to cutting-edge treatments but have also yielded promising results, contributing to the advancement of medical science.

Moreover, the success stories emerging from these trials have attracted further attention from global pharmaceutical companies and researchers, further solidifying Mexico’s position as a preferred destination for first-in-human trials.


Mexico’s active involvement in first-in-human trials reflects its commitment to advancing medical research and innovation. With its robust healthcare infrastructure, diverse population, and streamlined regulatory framework, Mexico has emerged as an attractive destination for conducting these critical trials.

By embracing this opportunity, Mexico has the potential to drive healthcare advancements, expand access to innovative therapies, and contribute to the global pursuit of improved patient care. The future of medical research in Mexico looks promising, and the nation’s participation in first-in-human trials is a testament to its growing influence in the field of healthcare innovation.

First-in-Human Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

First-in-Human Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
First-in-Human Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

First-in-Human Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

First-in-Human Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

First-in-Human Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

First-in-Human Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
First-in-Human Trials in Mexico

The Cohortias Team

First-in-Human Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

First-in-Human Trials in Mexico

Network & Partnerships